KY-1049

N/A

Report date: 2022/03/02 18:05:15

Base Information

Drug NameKY-1049

Drug Alias NameKY-1049

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Factor IXaAnti-Factor XBlood coagulation pathway activation

TargetsCoagulation factor IXCoagulation factor X

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKymab Ltd

China Registration ClassN/A

Develop Information

Active CompaniesKymab Ltd

Inactive CompaniesN/A

Active IndicationsHemophilia A

Inactive IndicationsN/A

Other Information

ATC CodeN/A